SCHEMBL17286245

SCHEMBL17286245

Cc1nc2cc3c(cc2[nH]1)Oc1ccccc1O3

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.50
SMN1; SMN2 Q16637 6/20 0.50
POLB P06746 6/20 0.50
NPC1 O15118 5/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 7/20 0.46
HPGD P15428 5/20 0.46
HCRTR1 O43613 1/20 0.46
NFKB1 P19838 1/20 0.46
STAT1 P42224 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
MAPT P10636 7/20 0.44
HSP90AA1 P07900 1/20 0.42
ESR2 Q92731 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GAA P10253 3/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4388276 0.77 KDM4E (0.59) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL30205255 0.77 KDM4E (0.59) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL3478941 0.76 CHRNB2 (0.45) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL8265473 0.76 CHRNB2 (0.45) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL13041691 0.76 ALDH1A1 (0.59) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL111276 0.74 RAB9A (0.66) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL29391888 0.74 RAB9A (0.66) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL12213872 0.74 MAPT (0.68) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL17702672 0.74 CHRNB2 (0.43) RAB9ASMN1; SMN2POLBNPC1MEN1
SCHEMBL8265318 0.74 MAPT (0.46) POLBALDH1A1KDM4EHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150336959-A1 Electronic Device MERCK PATENT GMBH (DE) 2015-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336959-A1 Electronic Device ETFB, ETFA, XPOT RAB9A 2505/4885SMN1; SMN2 2933/4885POLB 632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.